Antibody fragment (sdAb)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2e5/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2e5/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2e4/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2e4/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2e3/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2e3/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2e2/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2e2/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2e1/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2e1/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2e0/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2e0/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2df/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2df/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2de/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2de/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2dd/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2dd/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2dc/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2dc/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2db/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2db/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2da/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2da/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2d9/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2d9/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bc8dfbfee0e9012009ab2d8/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bc8dfbfee0e9012009ab2d8/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d9e400fefa5a70004f845d0/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d9e400fefa5a70004f845d0/5a84500fb8bc53001418401c.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d9e400fefa5a70004f845cf/5a84500fb8bc53001418401c.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d9e400fefa5a70004f845cf/5a84500fb8bc53001418401c.png"}]